Medical Condition News

RSS

Students invent system to shock irregular heart back into normal rhythm more safely and effectively

Johns Hopkins undergraduate students have invented a system to shock a dangerously irregular heart back into normal rhythm more safely and effectively.

16 Nov 2013

Study: Collaborative approaches can be effective in fighting high blood pressure

Uncontrolled high blood pressure rates continue to grow despite the availability of proven treatments, but collaborative approaches can be effective in fighting this deadly disease, according to a science advisory from the American Heart Association, the American College of Cardiology and the Centers for Disease Control and Prevention.

16 Nov 2013

Extracts made from herbs may improve learning and memory, study finds

Enhanced extracts made from special antioxidants in spearmint and rosemary improve learning and memory, a study in an animal model at Saint Louis University found.

15 Nov 2013

Study highlights major challenge faced by older adults with severe mental illnesses

Although older adults with serious mental illness didn't have more recorded physical illness and had fewer outpatient visits to primary care physicians, they made more medical emergency department visits and had considerably longer medical hospitalizations than older adults without mental illness according to a study conducted by researchers from the Regenstrief Institute and the Indiana University Center for Aging Research.

15 Nov 2013

Research could refine next generation of drugs to help treat dementia

A £1.1 million grant to understand how one of the brain's key neurotransmitters called 'acetylcholine' influences brain activity has been awarded to University of Bristol researchers. The Wellcome Trust award will help scientists understand more precisely how the release of acetylcholine is changing brain cell activity to influence memory and cognition.

15 Nov 2013

Zafgen presents safety, efficacy data from beloranib Phase 2 study at Obesity Week 2013

Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced final efficacy and safety data from its recently completed Phase 2 study of beloranib, a selective inhibitor of methionine aminopeptidase 2.

15 Nov 2013

Good quality care for young people with type-1 diabetes unevenly distributed in Ireland

New research launched today to coincide with World Diabetes Day which takes place tomorrow, 14th November 2013 revealed that good quality care for young people with type-1 diabetes is unevenly distributed throughout Ireland.

15 Nov 2013

Study: Sofrito helps to prevent cardiovascular diseases and cancer

The combination of tomato, olive oil, garlic and onion in a sofrito increases the amount of polyphenols and carotenoids. These bioactive compounds respectively help to prevent cardiovascular diseases and cancer.

15 Nov 2013

Conceive Plus Fertility Personal Lubricant receives FDA approval

The Pew Research Center reports that in the year 2011, the birth rate in the United States slid by 8%. That kind of statistic would indicate getting pregnant isn't as easy as it used to be. However, pharmaceutical manufacturer SASMAR aims to be at the forefront of helping couples to start families. The FDA has officially approved their OTC sperm friendly fertility personal lubricant, Conceive Plus for sale in the US market.

15 Nov 2013

Mayo Clinic Cardio-Rheumatology Clinic created for catching heart disease early in arthritis patients

Patients with rheumatoid arthritis, lupus and other chronic forms of inflammatory arthritis can face life-threatening complications, and heart disease tops the list. People with such rheumatic diseases are twice as likely as the average person to develop heart problems.

15 Nov 2013

High school sports played at higher altitudes linked with reduction in concussion rates

According to a recent study done by doctors at Cincinnati Children's Hospital Medical Center, high school athletes who play collision sports at higher altitudes are less likely to suffer from concussions than those who play at lower altitudes.

15 Nov 2013

European Commission grants marketing authorization for Bayer HealthCare's Xofigo injection

Bayer HealthCare announced today that the European Commission has granted marketing authorization for Xofigo (radium Ra 223 dichloride) solution for injection for the treatment of adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases. This decision follows a positive recommendation from the European Committee for Medicinal Products for Human Use in September of this year.

15 Nov 2013

New cholesterol guidelines represent the biggest change in more than 25 years

New cholesterol guidelines for identifying adults at risk for heart disease represent the biggest change in such expert advice in more than 25 years, according to Loyola University Health System preventive cardiology experts.

15 Nov 2013

Novel combination anti-psoriasis therapy targets genetic abnormalities in deeper layers of the skin

A novel combination anti-psoriasis therapy has potential for superior and longer-lasting therapeutic effects than current topical treatments by targeting genetic abnormalities in deeper layers of the skin. This research is being presented at the 2013 American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in San Antonio, Nov. 10-14.

15 Nov 2013

Diabetes people with low levels of physical activity are at greater risk of cardiovascular disease

The risk of cardiovascular complications in people with type 2 diabetes is directly related to the frequency and duration of physical exercise, according to results of a large follow-up study reported today on World Diabetes Day. Notably, those with low levels of physical activity had a 70% greater risk of cardiovascular death than those with higher levels.

15 Nov 2013

Private or government-subsidized insurance plans determine weight loss after bariatric surgery

Researchers found the biggest determinant of weight loss after bariatric surgery was not how long a patient was on a medically supervised diet program before surgery, but whether or not the patient had private or government-subsidized insurance.

15 Nov 2013

One-in-five surgically eligible patients denied insurance for bariatric surgery, study finds

University of North Carolina researchers found patients who were denied or delayed insurance approval for bariatric surgery, despite being cleared by their medical team, had a mortality rate three times higher than patients who received insurance approval without delay.

15 Nov 2013

Bariatric surgery safer when performed at accredited centers

Bariatric surgery is significantly safer when performed at an accredited center, according to new research presented here at the 30th Annual Meeting for the American Society for Metabolic and Bariatric Surgery during ObesityWeek 2013, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. The event is hosted by the ASMBS and The Obesity Society.

15 Nov 2013

Gastric bypass dramatically improves multiple cardiovascular risk factors in the long term

New research from the Cleveland Clinic shows most patients with diabetes and obesity who undergo gastric bypass not only experience remission of their diabetes and lose significant weight, but they also reduce their risk of having a heart attack by 40 percent and their risk for suffering a stroke by 42 percent, over a 10-year time horizon.

15 Nov 2013

FDA Advisory Committee votes in favor of Vanda's tasimelteon NDA for Non-24-Hour Disorder

Vanda Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration's Peripheral and Central Nervous System Drugs Advisory Committee voted overwhelmingly to recommend the approval of Vanda's New Drug Application for tasimelteon, proposed tradename HETLIOZ™, for the treatment of Non-24-Hour Disorder (Non-24) in the totally blind.

15 Nov 2013

Medical Condition News

Students invent system to shock irregular heart back into normal rhythm more safely and effectively

Study: Collaborative approaches can be effective in fighting high blood pressure

Extracts made from herbs may improve learning and memory, study finds

Study highlights major challenge faced by older adults with severe mental illnesses

Research could refine next generation of drugs to help treat dementia

Zafgen presents safety, efficacy data from beloranib Phase 2 study at Obesity Week 2013

Good quality care for young people with type-1 diabetes unevenly distributed in Ireland

Study: Sofrito helps to prevent cardiovascular diseases and cancer

Conceive Plus Fertility Personal Lubricant receives FDA approval

Mayo Clinic Cardio-Rheumatology Clinic created for catching heart disease early in arthritis patients

High school sports played at higher altitudes linked with reduction in concussion rates

European Commission grants marketing authorization for Bayer HealthCare's Xofigo injection

New cholesterol guidelines represent the biggest change in more than 25 years

Novel combination anti-psoriasis therapy targets genetic abnormalities in deeper layers of the skin

Diabetes people with low levels of physical activity are at greater risk of cardiovascular disease

Private or government-subsidized insurance plans determine weight loss after bariatric surgery

One-in-five surgically eligible patients denied insurance for bariatric surgery, study finds

Bariatric surgery safer when performed at accredited centers

Gastric bypass dramatically improves multiple cardiovascular risk factors in the long term

FDA Advisory Committee votes in favor of Vanda's tasimelteon NDA for Non-24-Hour Disorder

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News